Clinical Trial to Evaluate the Efficacy and Safety of SUBMO® as a Submucosal Injection Agent in Endoscopic Resection of Superficial Gastrointestinal Lesions.

by palligoelme@gmail.com | Mar 5, 2026 | Clinical Trials

​ Conditions: Colorectal Polyps Interventions: Device: SUBMO® Submucosal Injection; Device: Normal Saline (0.9% Sodium Chloride) with Surface Dye Injection Sponsors: i+Med S.Coop.; Hospital Universitario Basurto; Hospital de Cruces; Hospital Sant Joan de Deu; Fundació...

Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.

by palligoelme@gmail.com | Mar 5, 2026 | Clinical Trials

​ Conditions: Ventral Hernias; Cytoreductive Surgery Sponsors: Jules Bordet Institute Recruiting Conditions: Ventral Hernias; Cytoreductive Surgery Sponsors: Jules Bordet Institute Recruiting 

OPTIMISE-CKD Study_Dapagliflozin Effectiveness in CKD

by palligoelme@gmail.com | Mar 5, 2026 | Clinical Trials

​ Conditions: Chronic Kidney Disease Sponsors: AstraZeneca Recruiting Conditions: Chronic Kidney Disease Sponsors: AstraZeneca Recruiting 

Effects of Mobilization Using a Powered Lower-limb Exoskeleton With Prolonged Mechanical Ventilation

by palligoelme@gmail.com | Mar 5, 2026 | Clinical Trials

​ Conditions: Prolonged Mechanical Ventilation; Ventilator Weaning; Ventilator Dependent; Exoskeleton Device; Exercise Training Interventions: Device: lower-limb exoskeleton; Other: Standard medical treatment Sponsors: Fu Jen Catholic University Not yet...

A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer

by palligoelme@gmail.com | Mar 5, 2026 | Clinical Trials

​ Conditions: Biliary Tract Cancer Interventions: Drug: SHR-A1904 for Injection Sponsors: Suzhou Suncadia Biopharmaceuticals Co., Ltd. Not yet recruiting Conditions: Biliary Tract Cancer Interventions: Drug: SHR-A1904 for Injection Sponsors: Suzhou Suncadia...

Transcutaneous Spinal Cord Stimulation (tSCS) During Assisted Cycling Training for Incomplete Spinal Cord Injury.

by palligoelme@gmail.com | Mar 4, 2026 | Clinical Trials

​ Conditions: Incomplete Spinal Cord Injury (SCI) Interventions: Device: Transcutaneous spinal cord stimulation on the dorsal region between T11 and T12; Device: Sham transcutaneous spinal cord stimulation on the dorsal region between T11 and T12 Sponsors: Fundació...